Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations

There is currently great interest in the use of mesenchymal stem/stromal cells (MSCs) for the therapy of many diseases of animals and humans. However, we are still left with the serious challenges in explaining the beneficial effects of the cells. Hence, it is essential to work backward from dramatic results obtained in vivo to the cellular and molecular explanations in order to discover the secrets of MSCs. This review will focus on recent data that have changed the paradigms for understanding the therapeutic potentials of MSCs. J. Cell. Biochem. 113: 1460–1469, 2012. © 2011 Wiley Periodicals, Inc.

[1]  Ariel Miller,et al.  Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. , 2011, Autoimmunity reviews.

[2]  Ben D. MacArthur,et al.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.

[3]  Marilyn S. Rugg,et al.  The molecular basis of inter-alpha-inhibitor heavy chain transfer on to hyaluronan. , 2007, Biochemical Society transactions.

[4]  D. Prockop,et al.  Adult Bone Marrow Stem/Progenitor Cells (MSCs) Are Preconditioned by Microenvironmental "Niches" in Culture: A Two-Stage Hypothesis for Regulation of MSC Fate , 2005, Science's STKE.

[5]  H. Rubin Multistage carcinogenesis in cell culture. , 2001, Developments in biologicals.

[6]  G. Núñez,et al.  Cutting Edge: Critical Role for Mesothelial Cells in Necrosis-Induced Inflammation through the Recognition of IL-1α Released from Dying Cells1 , 2008, The Journal of Immunology.

[7]  A. Xiang,et al.  Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.

[8]  D. Benayahu,et al.  TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation*S⃞ , 2008, Journal of Biological Chemistry.

[9]  J. F. Staples,et al.  The respiratory effects of stanniocalcin-1 (STC-1) on intact mitochondria and cells: STC-1 uncouples oxidative phosphorylation and its actions are modulated by nucleotide triphosphates , 2007, Molecular and Cellular Endocrinology.

[10]  Grace Y Chen,et al.  Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.

[11]  R. Pochampally,et al.  Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. , 2004, Blood.

[12]  Darwin J. Prockop,et al.  Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Friedenstein,et al.  Stromal stem cells: marrow-derived osteogenic precursors. , 1988, Ciba Foundation symposium.

[14]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury , 2010, Proceedings of the National Academy of Sciences.

[15]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[16]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.

[17]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[18]  J. Tschopp,et al.  A pilot study of IL-1 inhibition by anakinra in acute gout , 2007, Arthritis research & therapy.

[19]  Y. Wan Regulatory T cells: immune suppression and beyond , 2010, Cellular and Molecular Immunology.

[20]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[21]  D. Prockop,et al.  Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Julie V. Harness,et al.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.

[23]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Marie C. M. Lin,et al.  MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling , 2011, RNA biology.

[25]  S. Raiden,et al.  Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile , 2010, PloS one.

[26]  P. Rameshwar,et al.  microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. , 2011, Current cancer therapy reviews.

[27]  J. Vilček,et al.  Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. , 2004, Cytokine & growth factor reviews.

[28]  Donald G Phinney,et al.  Defining the risks of mesenchymal stromal cell therapy. , 2010, Cytotherapy.

[29]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[30]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[31]  B. Sacchetti,et al.  Osteoprogenitors and the hematopoietic microenvironment. , 2011, Best practice & research. Clinical haematology.

[32]  R. Pochampally,et al.  Multipotent Stromal Cells Are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin‐1 , 2009, Stem cells.

[33]  D. Prockop Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[34]  R. Romieu-Mourez,et al.  Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.

[35]  M. Abdelrahim,et al.  Stanniocalcin-1 Suppresses Superoxide Generation in Macrophages through Induction of Mitochondrial Ucp2 , 2008 .

[36]  M. Kay,et al.  Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.

[37]  Fernando Ontiveros,et al.  The sterile inflammatory response. , 2010, Annual review of immunology.

[38]  R. Zhao,et al.  The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. , 2011, Experimental Hematology.

[39]  D. Prockop,et al.  Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[41]  R. Medzhitov Innate immunity: quo vadis? , 2010, Nature Immunology.

[42]  Y. Fujiyoshi,et al.  Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts , 2011, Proceedings of the National Academy of Sciences.

[43]  V. Sogos,et al.  Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile , 2011, Molecular Biology Reports.

[44]  Mesenchymal Stromal Cells , 2013, Stem Cell Biology and Regenerative Medicine.

[45]  Nikolay Bazhanov,et al.  Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs) , 2010, Journal of cellular and molecular medicine.

[46]  D. Prockop,et al.  Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. , 2008, Experimental hematology.

[47]  P. Delafontaine,et al.  Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. , 2009, Cell stem cell.

[48]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[49]  I. Sekiya,et al.  Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit , 2008, Cell and Tissue Research.

[50]  D. Prockop,et al.  Action at a Distance: Systemically Administered Adult Stem/Progenitor Cells (MSCs) Reduce Inflammatory Damage to the Cornea Without Engraftment and Primarily by Secretion of TNF‐α Stimulated Gene/Protein 6 , 2011, Stem cells.

[51]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[52]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[53]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[54]  L. Ortiz,et al.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.

[55]  Lu Fang,et al.  Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.

[56]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[57]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[58]  P. Hematti,et al.  Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. , 2009, Experimental hematology.

[59]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[60]  A. Burt,et al.  Mitochondrial Capture by a Transmissible Cancer , 2011, Science.

[61]  M. Andreeff,et al.  Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging , 2009, Stem cells.

[62]  R. Tompkins,et al.  Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.